XML 64 R50.htm IDEA: XBRL DOCUMENT v3.21.2
Stock Based Compensation (Tables)
9 Months Ended
Sep. 30, 2021
Share-based Payment Arrangement [Abstract]  
Summary of Changes to Issuances under 2017 Equity Plan The table below summarizes changes to the issuances under the Company’s 2017 Equity Plan for the periods indicated, excluding awards granted under the Company’s subsidiary incentive plans that are exchangeable for Tiptree common stock:
2017 Equity Plan
Number of shares (1)
Available for issuance as of December 31, 20203,788,417 
RSU, stock and option awards granted(50,251)
Exchanged for vested subsidiary awards(1,158,009)
Available for issuance as of September 30, 2021
2,580,157 
(1)    Excludes awards granted under the Company’s subsidiary incentive plans that are exchangeable for Tiptree common stock.
Summary of Changes to Issuances of RSUs under the 2017 Equity Plan
The following table presents changes to the issuances of RSUs and stock awards under the 2017 Equity Plan for the periods indicated:
Number of shares issuableWeighted average grant date fair value
Unvested units as of December 31, 2020953,145 $6.52 
Granted
50,251 7.21 
Vested(404,384)6.51 
Unvested units as of September 30, 2021
599,012 $6.59 

The following tables present the detail of the granted and vested RSUs and stock awards for the periods indicated:

Nine Months Ended
September 30,
Nine Months Ended
September 30,
Granted20212020Vested20212020
Directors50,251 56,485 Directors50,251 56,485 
Employees (1)
— 469,257 Employees354,133 474,721 
Total Granted50,251 525,742 Total Vested404,384 531,206 
Taxes(34,828)(53,438)
Net Vested369,556 477,768 
(1)    Includes 256,619 shares that vest ratably over three years and 212,638 shares that cliff vest in February 2023 for the nine months ended September 30, 2020.
The following table presents the Company's stock option activity for the current period:
Options outstandingWeighted average exercise price (in dollars per stock option)Weighted average grant date value (in dollars per stock option)Options exercisable
Balance, December 31, 20201,715,619 $6.49 $2.29 — 
Balance, September 30, 2021
1,715,619 $6.49 $2.29 712,542 
Weighted average remaining contractual term at September 30, 2021 (in years)
6.4
Schedule of Assumptions Used to Estimate the Fair Values of the PRSUs Granted
The following table presents the assumptions used to remeasure the fair value of the PRSUs as of September 30, 2021, which were granted in 2021 and classified as liability awards.

Valuation Input
Nine Months Ended September 30, 2021
AssumptionAverage
Historical volatility34.29%34.43%
Risk-free rate1.55%1.38%
Dividend yield1.59%1.40%
Cost of Equity9.84%9.88%
Expected term (years)1010
Summary of Changes to Issuances of Subsidiary RSU's under Subsidiary Incentive Plan
The following table presents changes to the issuances of subsidiary awards under the subsidiary incentive plans for the periods indicated:
Grant date fair value of equity shares issuable
Unvested balance as of December 31, 2020$4,305 
Granted1,278 
Vested(3,466)
Unvested balance as of September 30, 2021
$2,117 
Schedule of Assumptions Used to Estimate the Fair Values of the Stock Options Granted The following table presents the assumptions used to estimate the fair values of the stock options granted in 2020.
Valuation Input (1)
Nine Months Ended September 30, 2020
AssumptionAverage
Historical volatility27.60%N/A
Risk-free rate1.51%N/A
Dividend yield2.20%N/A
Expected term (years)7.0
(1) Not applicable for the nine months ended September 30, 2021 as there were no new grants during the period.
Schedule of Stock-based Compensation Expense and Related Income Tax Benefit
The following table presents total stock based compensation expense and the related income tax benefit recognized on the condensed consolidated statements of operations:
Three Months Ended
September 30,
Nine Months Ended
September 30,
2021202020212020
Employee compensation and benefits (1)
$1,401 $2,287 $3,372 $5,750 
Director compensation103 202 345 408 
Income tax benefit(316)(538)(781)(1,330)
Net stock based compensation expense$1,188 $1,951 $2,936 $4,828 
(1) Includes $350 related to liability awards recorded in other liabilities as of September 30, 2021.
Schedule of Additional Information on Total Non-vested Stock-based Compensation
Additional information on total non-vested stock based compensation is as follows:

As of September 30, 2021
Stock optionsRestricted stock awards and RSUs
Performance Restricted Stock Units
Unrecognized compensation cost related to non-vested awards$297 $2,988 $10,191 
Weighted - average recognition period (in years)1.020.683.23